Antitumor reagents for increasing sensitivity of malignant tumor cells to chemotherapy and immunotherapy

TW202633658APending Publication Date: 2026-08-16TAIPEI MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114138815
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-11
Filing Date
2025-10-08
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072715_001
    Figure TWG2TA001072715_001
  • Figure TWG2TA001072715_002
    Figure TWG2TA001072715_002
  • Figure TWG2TA001072715_003
    Figure TWG2TA001072715_003
Patent Text Reader

Abstract

The present disclosure relates to anti-tumor reagents for increasing the sensitivities of solid tumor cells to death stimuli induced by immunotherapy reagents, chemotherapy reagents, immune cell therapy, or radiation therapy. Said anti-tumor reagents suitable for use in the invention are selected from the group comprising a) a polynucleotide complementary to the transcript of the nuclear corepressor
Need to check novelty before this filing date? Find Prior Art